KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Other Non-Current Assets (2016 - 2026)

Amgen has reported Other Non-Current Assets over the past 18 years, most recently at $12.8 billion for Q1 2026.

  • For Q1 2026, Other Non-Current Assets rose 12.05% year-over-year to $12.8 billion; the TTM value through Mar 2026 reached $12.8 billion, up 12.05%, while the annual FY2025 figure was $12.7 billion, 27.49% up from the prior year.
  • Other Non-Current Assets for Q1 2026 was $12.8 billion at Amgen, up from $12.7 billion in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $13.2 billion in Q3 2025 and troughed at $5.9 billion in Q4 2022.
  • A 5-year average of $9.2 billion and a median of $9.0 billion in 2024 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: fell 9.58% in 2022 and later skyrocketed 62.93% in 2023.
  • Year by year, Other Non-Current Assets stood at $5.9 billion in 2022, then skyrocketed by 62.93% to $9.6 billion in 2023, then grew by 3.32% to $9.9 billion in 2024, then grew by 27.49% to $12.7 billion in 2025, then rose by 0.79% to $12.8 billion in 2026.
  • Business Quant data shows Other Non-Current Assets for AMGN at $12.8 billion in Q1 2026, $12.7 billion in Q4 2025, and $13.2 billion in Q3 2025.